首页> 美国卫生研究院文献>Chinese Medical Journal >Human leukocyte antigen (HLA) A-C-B-DRB1-DQB1 haplotype segregation analysis among 2152 families in China and the comparison to expectation-maximization algorithm result
【2h】

Human leukocyte antigen (HLA) A-C-B-DRB1-DQB1 haplotype segregation analysis among 2152 families in China and the comparison to expectation-maximization algorithm result

机译:人白细胞抗原(HLA)A-C-B-DRB1-DQB1单倍型分离分析在中国的2152个家庭中与预期最大化算法的比较

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Human leukocyte antigen (HLA) is the major histocompatibility complex for humans. Previous studies have shown that high-resolution HLA matching can reduce graft vs. host disease and improve the outcome of hematopoietic stem cell transplantation (HSCT). Unrelated donor HSCT is very important when patients have no HLA-identical sibling donors. However, the chance of finding an available unrelated donor is not equal for every patient. Previous studies in Western countries have found that the HLA haplotype frequency (HF) could help to predict the probability of identifying HLA allele-matched unrelated donors.[1] However, the HLA system shows ethnic diversity and regional disparity. Therefore, if we want to use the HLA haplotype tool in China, a reliable HLA haplotype database for the Chinese population needs to be established.
机译:人白细胞抗原(HLA)是人类的主要组织相容性复合物。以前的研究表明,高分辨率HLA匹配可以减少移植物与宿主疾病,改善造血干细胞移植的结果(HSCT)。当患者没有HLA相同的兄弟提供者时,无关的供体HSCT非常重要。然而,找到可用的无关捐助者的机会对每个患者不等。以前在西方国家的研究发现HLA单倍型频率(HF)可以有助于预测鉴定HLA等位基因匹配的无关捐赠者的可能性。[1]但是,HLA系统显示了种族多样性和区域差异。因此,如果我们想在中国使用HLA单倍型工具,需要建立用于中国人口的可靠的HLA单倍型数据库。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号